Dr. McCoy honored for extraordinary commitment and dedication to patients and the community
Roanoke, Virginia and The Woodlands, Texas (May 19, 2014) – Blue Ridge Cancer Care (BRCC), a practice in The US Oncology Network, is pleased to announce that medical oncologist, Harry McCoy, M.D., was named both the local and national winner of the prestigious Frist Humanitarian Physician Award. The local recognition came from LewisGale Hospital Montgomery, while the national award was received from the parent company of LewisGale Regional Health System, Hospital Corporation of America (HCA).
The 42nd annual Frist Humanitarian National Awards are HCA’s highest honor. Each year an employee, a volunteer and a physician are selected to receive the award from local award winners around the country for demonstrating extraordinary concern for the welfare and happiness of patients and their communities. Dr. McCoy received the national physician award on April 28 in Nashville at a special ceremony, along with a $10,000 donation to his favorite charity. He chose to donate his award money to the Sojourn Center, an organization dedicated to developing a hospice house and end of life center.
“We could not be more proud, nor happy, that Dr. McCoy was selected for this award,” said William Fintel, M.D., practice president, BRCC. “He has been tireless throughout his career on behalf of his patients and the entire community that he serves. Receiving the Frist Humanitarian Award here in Virginia, and simultaneously the national award, is an achievement that no one could deserve more. He is an accomplished physician, a dedicated husband and father and a natural leader in our oncology community. He places excellence in patient care at the top of his “to-do” list each morning. We congratulate him and thank his fine family for their patience as he continues to be an integral part of our cancer program and the very fabric of southwest Virginia.”
Established in 1971, the Frist Humanitarian Awards honor outstanding individuals for their humanitarian and volunteer activities. The awards are given annually in recognition of the caring spirit and philanthropic work of the late Dr. Thomas Frist Sr., a founder of HCA. Employees, volunteers and medical staff members who demonstrate commitment and dedication to providing outstanding care and humanitarianism are selected from across the country, and honorees are recognized at the local level. Three national recipients are then chosen from more than 200 hospital-level honorees.
Dr. McCoy has been in private practice serving patients in Virginia since 1992. He joined Blue Ridge Cancer Care in 1999. A native of Norfolk, Virginia, he received a B.A. in psychology from the University of Virginia. He then went on to the University of Virginia’s Medical School and obtained his M.D. degree. Dr. McCoy did his internship, residency and a four year fellowship in hematology and oncology at the University of Florida. He is board certified in medical oncology, hematology, and internal medicine, as well as hospice and palliative care.
About Blue Ridge Cancer Care
For more than 33 years, Blue Ridge Cancer Care (BRCC) has helped patients with cancer and blood disorders get the most out of life. As a privately-owned practice of 18 physicians, BRCC serves patients in nine locations throughout Southwest Virginia. The high-quality care provided at BRCC includes state-of-the-art technologies and treatments delivered in a compassionate and comfortable setting. BRCC’s model of integrated community-based care maximizes patient and family convenience, while offering patients comprehensive care close to home.
Blue Ridge Cancer Care is united in healing with The US Oncology Network, one of the nation’s largest networks of integrated community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. As an affiliate of The US Oncology Network, BRCC is united with nearly 1,000 physicians nationwide. Blue Ridge Cancer Care participates in clinical trials through US Oncology Research, which has played a role in 48 FDA-approved cancer therapies, nearly one-third of all cancer therapies approved by the FDA to date. For more information, visit www.usoncology.com.